Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · IEX Real-Time Price · USD
1.850
+0.005 (0.27%)
At close: Jun 18, 2024, 4:00 PM
1.900
+0.050 (2.70%)
After-hours: Jun 18, 2024, 7:38 PM EDT

Rockwell Medical Revenue

Rockwell Medical had revenue of $86.62M in the twelve months ending March 31, 2024, with 13.45% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $22.68M with 15.29% year-over-year growth. In the year 2023, Rockwell Medical had annual revenue of $83.61M with 14.84% growth.

Revenue (ttm)
$86.62M
Revenue Growth
+13.45%
P/S Ratio
0.65
Revenue / Employee
$365,485
Employees
237
Market Cap
56.08M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202383.61M10.80M14.84%
Dec 31, 202272.81M10.88M17.57%
Dec 31, 202161.93M-266.00K-0.43%
Dec 31, 202062.20M894.00K1.46%
Dec 31, 201961.30M-2.09M-3.29%
Dec 31, 201863.39M6.09M10.63%
Dec 31, 201757.30M4.02M7.54%
Dec 31, 201653.28M-2.07M-3.73%
Dec 31, 201555.35M1.16M2.14%
Dec 31, 201454.19M1.81M3.45%
Dec 31, 201352.38M2.54M5.09%
Dec 31, 201249.84M876.16K1.79%
Dec 31, 201148.97M-10.59M-17.78%
Dec 31, 201059.55M4.83M8.82%
Dec 31, 200954.73M3.06M5.93%
Dec 31, 200851.67M8.62M20.03%
Dec 31, 200743.05M14.41M50.30%
Dec 31, 200628.64M943.90K3.41%
Dec 31, 200527.69M9.75M54.33%
Dec 31, 200417.94M2.97M19.87%
Dec 31, 200314.97M3.47M30.22%
Dec 31, 200211.50M2.48M27.51%
Dec 31, 20019.02M1.56M20.90%
Dec 31, 20007.46M768.09K11.48%
Dec 31, 19996.69M1.42M26.86%
Dec 31, 19985.27M1.95M58.87%
Dec 31, 19973.32M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bionano Genomics 37.47M
LAVA Therapeutics 13.63M
DURECT 8.32M
Adlai Nortye 5.00M
Enzo Biochem 4.72M
VolitionRx 797.03K
Ovid Therapeutics 473.54K
Revenue Rankings